Global Hemophilia Treatment Market Size, Status and Forecast 2020-2026

May 2020 | 96 pages | ID: G608CCC83B86EN
QYResearch

Abstracts

This report focuses on the global Hemophilia Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Hemophilia Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

• CSL Behring
• Baxalta
• Pfizer Inc
• BioMarin
• Bayer Healthcare
• Biogen
• Novo Nordisk
• Roche
• Takeda

Market segment by Type, the product can be split into

• On-demand
• prophylaxis

Market segment by Application, split into

• Replacement therapy
• ITI therapy
• Gene therapy

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Hemophilia Treatment status, future forecast, growth opportunity, key market and key players.
• To present the Hemophilia Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Hemophilia Treatment are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Hemophilia Treatment Revenue
1.4 Market Analysis by Type
  1.4.1 Global Hemophilia Treatment Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 On-demand
  1.4.3 prophylaxis
1.5 Market by Application
  1.5.1 Global Hemophilia Treatment Market Share by Application: 2020 VS 2026
  1.5.2 Replacement therapy
  1.5.3 ITI therapy
  1.5.4 Gene therapy
1.6 Study Objectives
1.7 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Hemophilia Treatment Market Perspective (2015-2026)
2.2 Hemophilia Treatment Growth Trends by Regions
  2.2.1 Hemophilia Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Hemophilia Treatment Historic Market Share by Regions (2015-2020)
  2.2.3 Hemophilia Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Hemophilia Treatment Market Growth Strategy
  2.3.6 Primary Interviews with Key Hemophilia Treatment Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Hemophilia Treatment Players by Market Size
  3.1.1 Global Top Hemophilia Treatment Players by Revenue (2015-2020)
  3.1.2 Global Hemophilia Treatment Revenue Market Share by Players (2015-2020)
  3.1.3 Global Hemophilia Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Hemophilia Treatment Market Concentration Ratio
  3.2.1 Global Hemophilia Treatment Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Hemophilia Treatment Revenue in 2019
3.3 Hemophilia Treatment Key Players Head office and Area Served
3.4 Key Players Hemophilia Treatment Product Solution and Service
3.5 Date of Enter into Hemophilia Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Hemophilia Treatment Historic Market Size by Type (2015-2020)
4.2 Global Hemophilia Treatment Forecasted Market Size by Type (2021-2026)

5 HEMOPHILIA TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Hemophilia Treatment Market Size by Application (2015-2020)
5.2 Global Hemophilia Treatment Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Hemophilia Treatment Market Size (2015-2020)
6.2 Hemophilia Treatment Key Players in North America (2019-2020)
6.3 North America Hemophilia Treatment Market Size by Type (2015-2020)
6.4 North America Hemophilia Treatment Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Hemophilia Treatment Market Size (2015-2020)
7.2 Hemophilia Treatment Key Players in Europe (2019-2020)
7.3 Europe Hemophilia Treatment Market Size by Type (2015-2020)
7.4 Europe Hemophilia Treatment Market Size by Application (2015-2020)

8 CHINA

8.1 China Hemophilia Treatment Market Size (2015-2020)
8.2 Hemophilia Treatment Key Players in China (2019-2020)
8.3 China Hemophilia Treatment Market Size by Type (2015-2020)
8.4 China Hemophilia Treatment Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Hemophilia Treatment Market Size (2015-2020)
9.2 Hemophilia Treatment Key Players in Japan (2019-2020)
9.3 Japan Hemophilia Treatment Market Size by Type (2015-2020)
9.4 Japan Hemophilia Treatment Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Hemophilia Treatment Market Size (2015-2020)
10.2 Hemophilia Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Hemophilia Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Hemophilia Treatment Market Size by Application (2015-2020)

11 INDIA

11.1 India Hemophilia Treatment Market Size (2015-2020)
11.2 Hemophilia Treatment Key Players in India (2019-2020)
11.3 India Hemophilia Treatment Market Size by Type (2015-2020)
11.4 India Hemophilia Treatment Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Hemophilia Treatment Market Size (2015-2020)
12.2 Hemophilia Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Hemophilia Treatment Market Size by Type (2015-2020)
12.4 Central & South America Hemophilia Treatment Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 CSL Behring
  13.1.1 CSL Behring Company Details
  13.1.2 CSL Behring Business Overview and Its Total Revenue
  13.1.3 CSL Behring Hemophilia Treatment Introduction
  13.1.4 CSL Behring Revenue in Hemophilia Treatment Business (2015-2020))
  13.1.5 CSL Behring Recent Development
13.2 Baxalta
  13.2.1 Baxalta Company Details
  13.2.2 Baxalta Business Overview and Its Total Revenue
  13.2.3 Baxalta Hemophilia Treatment Introduction
  13.2.4 Baxalta Revenue in Hemophilia Treatment Business (2015-2020)
  13.2.5 Baxalta Recent Development
13.3 Pfizer Inc
  13.3.1 Pfizer Inc Company Details
  13.3.2 Pfizer Inc Business Overview and Its Total Revenue
  13.3.3 Pfizer Inc Hemophilia Treatment Introduction
  13.3.4 Pfizer Inc Revenue in Hemophilia Treatment Business (2015-2020)
  13.3.5 Pfizer Inc Recent Development
13.4 BioMarin
  13.4.1 BioMarin Company Details
  13.4.2 BioMarin Business Overview and Its Total Revenue
  13.4.3 BioMarin Hemophilia Treatment Introduction
  13.4.4 BioMarin Revenue in Hemophilia Treatment Business (2015-2020)
  13.4.5 BioMarin Recent Development
13.5 Bayer Healthcare
  13.5.1 Bayer Healthcare Company Details
  13.5.2 Bayer Healthcare Business Overview and Its Total Revenue
  13.5.3 Bayer Healthcare Hemophilia Treatment Introduction
  13.5.4 Bayer Healthcare Revenue in Hemophilia Treatment Business (2015-2020)
  13.5.5 Bayer Healthcare Recent Development
13.6 Biogen
  13.6.1 Biogen Company Details
  13.6.2 Biogen Business Overview and Its Total Revenue
  13.6.3 Biogen Hemophilia Treatment Introduction
  13.6.4 Biogen Revenue in Hemophilia Treatment Business (2015-2020)
  13.6.5 Biogen Recent Development
13.7 Novo Nordisk
  13.7.1 Novo Nordisk Company Details
  13.7.2 Novo Nordisk Business Overview and Its Total Revenue
  13.7.3 Novo Nordisk Hemophilia Treatment Introduction
  13.7.4 Novo Nordisk Revenue in Hemophilia Treatment Business (2015-2020)
  13.7.5 Novo Nordisk Recent Development
13.8 Roche
  13.8.1 Roche Company Details
  13.8.2 Roche Business Overview and Its Total Revenue
  13.8.3 Roche Hemophilia Treatment Introduction
  13.8.4 Roche Revenue in Hemophilia Treatment Business (2015-2020)
  13.8.5 Roche Recent Development
13.9 Takeda
  13.9.1 Takeda Company Details
  13.9.2 Takeda Business Overview and Its Total Revenue
  13.9.3 Takeda Hemophilia Treatment Introduction
  13.9.4 Takeda Revenue in Hemophilia Treatment Business (2015-2020)
  13.9.5 Takeda Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Hemophilia Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Hemophilia Treatment Revenue
Table 3. Ranking of Global Top Hemophilia Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Hemophilia Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of On-demand
Table 6. Key Players of prophylaxis
Table 7. Global Hemophilia Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Hemophilia Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Hemophilia Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Hemophilia Treatment Market Share by Regions (2015-2020)
Table 11. Global Hemophilia Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Hemophilia Treatment Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Hemophilia Treatment Market Growth Strategy
Table 17. Main Points Interviewed from Key Hemophilia Treatment Players
Table 18. Global Hemophilia Treatment Revenue by Players (2015-2020) (Million US$)
Table 19. Global Hemophilia Treatment Market Share by Players (2015-2020)
Table 20. Global Top Hemophilia Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hemophilia Treatment as of 2019)
Table 21. Global Hemophilia Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Hemophilia Treatment Product Solution and Service
Table 24. Date of Enter into Hemophilia Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Hemophilia Treatment Market Size by Type (2015-2020) (Million US$)
Table 27. Global Hemophilia Treatment Market Size Share by Type (2015-2020)
Table 28. Global Hemophilia Treatment Revenue Market Share by Type (2021-2026)
Table 29. Global Hemophilia Treatment Market Size Share by Application (2015-2020)
Table 30. Global Hemophilia Treatment Market Size by Application (2015-2020) (Million US$)
Table 31. Global Hemophilia Treatment Market Size Share by Application (2021-2026)
Table 32. North America Key Players Hemophilia Treatment Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Hemophilia Treatment Market Share (2019-2020)
Table 34. North America Hemophilia Treatment Market Size by Type (2015-2020) (Million US$)
Table 35. North America Hemophilia Treatment Market Share by Type (2015-2020)
Table 36. North America Hemophilia Treatment Market Size by Application (2015-2020) (Million US$)
Table 37. North America Hemophilia Treatment Market Share by Application (2015-2020)
Table 38. Europe Key Players Hemophilia Treatment Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Hemophilia Treatment Market Share (2019-2020)
Table 40. Europe Hemophilia Treatment Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Hemophilia Treatment Market Share by Type (2015-2020)
Table 42. Europe Hemophilia Treatment Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Hemophilia Treatment Market Share by Application (2015-2020)
Table 44. China Key Players Hemophilia Treatment Revenue (2019-2020) (Million US$)
Table 45. China Key Players Hemophilia Treatment Market Share (2019-2020)
Table 46. China Hemophilia Treatment Market Size by Type (2015-2020) (Million US$)
Table 47. China Hemophilia Treatment Market Share by Type (2015-2020)
Table 48. China Hemophilia Treatment Market Size by Application (2015-2020) (Million US$)
Table 49. China Hemophilia Treatment Market Share by Application (2015-2020)
Table 50. Japan Key Players Hemophilia Treatment Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Hemophilia Treatment Market Share (2019-2020)
Table 52. Japan Hemophilia Treatment Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Hemophilia Treatment Market Share by Type (2015-2020)
Table 54. Japan Hemophilia Treatment Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Hemophilia Treatment Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Hemophilia Treatment Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Hemophilia Treatment Market Share (2019-2020)
Table 58. Southeast Asia Hemophilia Treatment Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Hemophilia Treatment Market Share by Type (2015-2020)
Table 60. Southeast Asia Hemophilia Treatment Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Hemophilia Treatment Market Share by Application (2015-2020)
Table 62. India Key Players Hemophilia Treatment Revenue (2019-2020) (Million US$)
Table 63. India Key Players Hemophilia Treatment Market Share (2019-2020)
Table 64. India Hemophilia Treatment Market Size by Type (2015-2020) (Million US$)
Table 65. India Hemophilia Treatment Market Share by Type (2015-2020)
Table 66. India Hemophilia Treatment Market Size by Application (2015-2020) (Million US$)
Table 67. India Hemophilia Treatment Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Hemophilia Treatment Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Hemophilia Treatment Market Share (2019-2020)
Table 70. Central & South America Hemophilia Treatment Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Hemophilia Treatment Market Share by Type (2015-2020)
Table 72. Central & South America Hemophilia Treatment Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Hemophilia Treatment Market Share by Application (2015-2020)
Table 74. CSL Behring Company Details
Table 75. CSL Behring Business Overview
Table 76. CSL Behring Product
Table 77. CSL Behring Revenue in Hemophilia Treatment Business (2015-2020) (Million US$)
Table 78. CSL Behring Recent Development
Table 79. Baxalta Company Details
Table 80. Baxalta Business Overview
Table 81. Baxalta Product
Table 82. Baxalta Revenue in Hemophilia Treatment Business (2015-2020) (Million US$)
Table 83. Baxalta Recent Development
Table 84. Pfizer Inc Company Details
Table 85. Pfizer Inc Business Overview
Table 86. Pfizer Inc Product
Table 87. Pfizer Inc Revenue in Hemophilia Treatment Business (2015-2020) (Million US$)
Table 88. Pfizer Inc Recent Development
Table 89. BioMarin Company Details
Table 90. BioMarin Business Overview
Table 91. BioMarin Product
Table 92. BioMarin Revenue in Hemophilia Treatment Business (2015-2020) (Million US$)
Table 93. BioMarin Recent Development
Table 94. Bayer Healthcare Company Details
Table 95. Bayer Healthcare Business Overview
Table 96. Bayer Healthcare Product
Table 97. Bayer Healthcare Revenue in Hemophilia Treatment Business (2015-2020) (Million US$)
Table 98. Bayer Healthcare Recent Development
Table 99. Biogen Company Details
Table 100. Biogen Business Overview
Table 101. Biogen Product
Table 102. Biogen Revenue in Hemophilia Treatment Business (2015-2020) (Million US$)
Table 103. Biogen Recent Development
Table 104. Novo Nordisk Company Details
Table 105. Novo Nordisk Business Overview
Table 106. Novo Nordisk Product
Table 107. Novo Nordisk Revenue in Hemophilia Treatment Business (2015-2020) (Million US$)
Table 108. Novo Nordisk Recent Development
Table 109. Roche Business Overview
Table 110. Roche Product
Table 111. Roche Company Details
Table 112. Roche Revenue in Hemophilia Treatment Business (2015-2020) (Million US$)
Table 113. Roche Recent Development
Table 114. Takeda Company Details
Table 115. Takeda Business Overview
Table 116. Takeda Product
Table 117. Takeda Revenue in Hemophilia Treatment Business (2015-2020) (Million US$)
Table 118. Takeda Recent Development
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Hemophilia Treatment Market Share by Type: 2020 VS 2026
Figure 2. On-demand Features
Figure 3. prophylaxis Features
Figure 4. Global Hemophilia Treatment Market Share by Application: 2020 VS 2026
Figure 5. Replacement therapy Case Studies
Figure 6. ITI therapy Case Studies
Figure 7. Gene therapy Case Studies
Figure 8. Hemophilia Treatment Report Years Considered
Figure 9. Global Hemophilia Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Hemophilia Treatment Market Share by Regions: 2020 VS 2026
Figure 11. Global Hemophilia Treatment Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Hemophilia Treatment Market Share by Players in 2019
Figure 14. Global Top Hemophilia Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hemophilia Treatment as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Hemophilia Treatment Revenue in 2019
Figure 16. North America Hemophilia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Hemophilia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Hemophilia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Hemophilia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Hemophilia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Hemophilia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Hemophilia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. CSL Behring Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. CSL Behring Revenue Growth Rate in Hemophilia Treatment Business (2015-2020)
Figure 25. Baxalta Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Baxalta Revenue Growth Rate in Hemophilia Treatment Business (2015-2020)
Figure 27. Pfizer Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Pfizer Inc Revenue Growth Rate in Hemophilia Treatment Business (2015-2020)
Figure 29. BioMarin Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. BioMarin Revenue Growth Rate in Hemophilia Treatment Business (2015-2020)
Figure 31. Bayer Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Bayer Healthcare Revenue Growth Rate in Hemophilia Treatment Business (2015-2020)
Figure 33. Biogen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Biogen Revenue Growth Rate in Hemophilia Treatment Business (2015-2020)
Figure 35. Novo Nordisk Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Novo Nordisk Revenue Growth Rate in Hemophilia Treatment Business (2015-2020)
Figure 37. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Roche Revenue Growth Rate in Hemophilia Treatment Business (2015-2020)
Figure 39. Takeda Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Takeda Revenue Growth Rate in Hemophilia Treatment Business (2015-2020)
Figure 41. Bottom-up and Top-down Approaches for This Report
Figure 42. Data Triangulation
Figure 43. Key Executives Interviewed